Sinovac vaccine recipients more likely to develop severe COVID-19 than Pfizer: Study

Published: 14 April 2022
on channel: CNA

53,081

451

A Singapore study has found that recipients of the Sinovac vaccine are nearly five times more likely to experience severe symptoms from COVID-19 than those who received Pfizer shots. The study involved about 2.7 million adults who received two doses under the national vaccination programme. CNA spoke to Dr Calvin Chiew, Associate Consultant at the National Public Health and Epidemiology Unit at NCID. He is one of the authors of the study.

Subscribe to our channel here: https://cna.asia/youtubesub

Subscribe to our news service on Telegram: https://cna.asia/telegram

Follow us:
CNA: https://cna.asia
CNA Lifestyle: http://www.cnalifestyle.com
Facebook:   / channelnewsasia
Instagram:   / channelnewsasia
Twitter:   / channelnewsasia

Watch video Sinovac vaccine recipients more likely to develop severe COVID-19 than Pfizer: Study online, duration hours minute second in high quality that is uploaded to the channel CNA 14 April 2022. Share the link to the video on social media so that your subscribers and friends will also watch this video. This video clip has been viewed 53,081 times and liked it 451 visitors.

121

00:00:00